Drug Shortage Report for APO-RASAGILINE

Last updated on 2022-08-05 History
Report ID 151360
Drug Identification Number 02404680
Brand name APO-RASAGILINE
Common or Proper name RASAGILINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) RASAGILINE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N04BD
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-12-13
Estimated end date 2022-09-09
Actual end date
Shortage status Actual shortage
Updated date 2022-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-12-17 English Compare
v2 2021-12-17 French Compare
v3 2021-12-17 English Compare
v4 2021-12-17 French Compare
v5 2022-02-08 English Compare
v6 2022-02-08 French Compare
v7 2022-03-04 English Compare
v8 2022-03-04 French Compare
v9 2022-05-06 English Compare
v10 2022-05-06 French Compare
v11 2022-07-22 English Compare
v12 2022-07-22 French Compare
v13 2022-08-05 English Compare
v14 2022-08-05 French Compare

Showing 1 to 14 of 14